Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Current Leases (2019 - 2025)

Silence Therapeutics (SLN) has disclosed Current Leases for 7 consecutive years, with $89000.0 as the latest value for Q4 2025.

  • Quarterly Current Leases fell 23.93% to $89000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $89000.0 through Dec 2025, down 23.93% year-over-year, with the annual reading at $89000.0 for FY2025, 23.93% down from the prior year.
  • Current Leases hit $89000.0 in Q4 2025 for Silence Therapeutics, up from $85000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $523126.0 in Q4 2022 to a low of $60000.0 in Q1 2025.
  • Historically, Current Leases has averaged $182995.7 across 5 years, with a median of $117000.0 in 2024.
  • Biggest five-year swings in Current Leases: plummeted 58.99% in 2021 and later surged 183.26% in 2022.
  • Year by year, Current Leases stood at $184677.5 in 2021, then soared by 183.26% to $523126.0 in 2022, then tumbled by 57.53% to $222166.2 in 2023, then plummeted by 47.34% to $117000.0 in 2024, then dropped by 23.93% to $89000.0 in 2025.
  • Business Quant data shows Current Leases for SLN at $89000.0 in Q4 2025, $85000.0 in Q3 2025, and $60000.0 in Q1 2025.